Epigenetic regulation of bone morphogenetic protein-6 gene expression in breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 105, Issue 1-5, 2007, Pages 91-97

  Zhang, Ming ^a   Wang, Qing ^a   Yuan, Wei ^a   Yang, Shuang ^a   Wang, Xu ^a   Yan, Ji Dong ^a   Du, Jun ^a   Yin, Jian ^b   Gao, Song Yuan ^b   Sun, Bao Cun ^b   Zhu, Tian Hui ^a  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

5 aza 2 Deoxycytidine (5 aza dC); Bisulfite sequencing (BSG); Epigenetic regulation; Estrogen receptor (ER); Methylation sensitive enzyme restriction PCR (MSRE PCR); Methylation specific PCR (MSP)

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BONE MORPHOGENETIC PROTEIN 6; ESTROGEN; ESTROGEN RECEPTOR; MESSENGER RNA;

ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA FLANKING REGION; EPIGENETICS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM;

BASE SEQUENCE; BONE MORPHOGENETIC PROTEINS; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; DNA PRIMERS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RNA, MESSENGER;

EID: 34547702265     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.01.002     Document Type: Article

References (26)

1. Akiyoshi T., Uchida K., and Tateyama S. Expression of bone morphogenetic protein-6 and bone morphogenetic protein receptors in myoepithelial cells of canine mammary gland tumors. Vet. Pathol. 41 (2004) 154-163
2. Clement J.H., Sanger J., and Hoffken K. Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor. Int. J. Cancer 80 (1999) 250-256
3. Hamdy F.C., Autzen P., Robinson M.C., Horne C.H., Neal D.E., and Robson C.N. Immunolocalization and messenger RNA expression of bone morphogenetic protein 6 in human benign and malignant prostatic tissue. Cancer Res. 57 (1997) 4427-4431
4. Zhang M., Yan J.D., Zhang L., Wang Q., Lu S.J., Zhang J., and Zhu T.H. Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen. Chin. Med. J. (Engl.) 118 (2005) 1629-1636
5. Sheikh M.S., Garcia M., Pujol P., Fontana J.A., and Rochefort H. Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers?. Invasion Metastasis 14 (1994) 329-336
6. Maki D.D., and Grossman R.I. Patterns of disease spread in metastatic breast carcinoma: influence of estrogen and progesterone receptor status. Am. J. Neuroradiol. 21 (2000) 1064-1066
7. Szyf M., Pakneshan P., and Rabbani S.A. DNA methylation and breast cancer. Biochem. Pharmacol. 68 (2004) 1187-1197
8. Perry A.S., Foley R., Woodson K., and Lawler M. The emerging roles of DNA methylation in the clinical management of prostate cancer. Endocr. Relat. Cancer 13 (2006) 357-377
9. Topaloglu O., Hoque M.O., Tokumaru Y., Lee J., Ratovitski E., Sidransky D., and Moon C.S. Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin. Cancer Res. 10 (2004) 2284-2288
10. Matsubayashi H., Canto M., Sato N., Klein A., Abe T., Yamashita K., Yeo C.J., Kalloo A., Hruban R., and Goggins M. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res. 66 (2006) 1208-1217
11. Schmutte C., and Jones P.A. Involvement of DNA methylation in human carcinogenesis. Biol. Chem. 379 (1998) 377-388
12. Leung S.Y., Yuen S.T., Chung L.P., Chu K.M., Chan A.S., and Ho J.C. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res. 59 (1999) 159-164
13. Palmisano W.A., Divine K.K., Saccomanno G., Gilliland F.D., Baylin S.B., Herman J.G., and Belinsky S.A. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 60 (2000) 5954-5958
14. Tamada H., Kitazawa R., Gohji K., and Kitazawa S. Epigenetic regulation of human bone morphogenetic protein 6 gene expression in prostate cancer. J. Bone Miner. Res. 16 (2001) 487-496
15. Melnikov A.A., Gartenhaus R.B., Levenson A.S., Motchoulskaia N.A., and Levenson Chernokhvostov V.V. MSRE-PCR for analysis of gene-specific DNA methylation. Nucl. Acids Res. 33 (2005) e93
16. Frommer M., McDonald L.E., Miller D.S., Collis C.M., Watt F., Grigg G.W., Molloy P.L., and Paul C.L. A, genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 89 (1992) 1827-1831
17. Lau Q.C., Raja E., Salto-Tellez M., Liu Q., Ito K., Inoue M., Putti T.C., Loh M., Ko T.K., Huang C., Bhalla K.N., Zhu T., Ito Y., and Sukumar S. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res. 66 (2006) 6512-6520
18. Reynolds P.A., Sigaroudinia M., Zardo G., Wilson M.B., Benton G.M., Miller C.J., Hong C., Fridlyand J., Costello J.F., and Tlsty T.D. Tumor suppressor P16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. J. Biol. Chem. 281 (2006) 24790-24802
19. Lui E.L., Loo W.T., Zhu L., Cheung M.N., and Chow L.W. DNA hypermethylation of TIMP3 gene in invasive breast ductal carcinoma. Biomed. Pharmacother. Suppl. 2 (2005) S363-S365
20. Pakneshan P., Szyf M., Farias-Eisner R., and Rabbani S.A. Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. J. Biol. Chem. 279 (2004) 31735-31744
21. Shteper P.J., Zcharia E., Ashhab Y., Peretz T., Vlodavsky I., and Ben-Yehuda D. Role of promoter methylation in regulation of the mammalian heparanase gene. Oncogene 22 (2003) 7737-7749
22. de Silva Rudland S., Martin L., Roshanlall C., Winstanley J., Leinster S., Platt-Higgins A., Carroll J., West C., Barraclough R., and Rudland P. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. Clin. Cancer Res. 12 (2006) 1192-1200
23. Sriussadaporn S., Srimuninnimit V., Ploybutr S., Tanlakit M., Chearskul S., Chakrapee-Sirisuk S., Nitiyanant W., Vannasaeng S., Sinlarat P., and Vichayanrat A. Association between estrogen receptor concentration in breast cancer tissue and bone mineral density. J. Med. Assoc. Thai. 85 (2002) 327-333
24. Fotovati A., Fujii T., Yamaguchi M., Kage M., Shirouzu K., Oie S., Basaki Y., Ono M., Yamana H., and Kuwano M. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells. Clin. Cancer Res. 12 (2006) 3010-3018
25. Paquette B., Bisson M., Therriault H., Lemay R., Pare M., Banville P., and Cantin A.M. Activation of matrix metalloproteinase-2 and -9 by 2- and 4-hydroxyestradiol. J. Steroid Biochem. Mol. Biol. 87 (2003) 65-73
26. Dai J., Keller J., Zhang J., Lu Y., Yao Z., and Keller E.T. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. Cancer Res. 65 (2005) 8274-8285